# Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis

> **NCT04645589** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 72 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Myfortic

## Key facts

- **NCT ID:** NCT04645589
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-16
- **Primary completion:** 2025-06-13
- **Final completion:** 2025-06-13
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645589, "Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04645589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*